Overcoming fratricide of CD86 targeting CAR-T cells by defined logic-gate CAR strategy.
Saved in:
| Title: | Overcoming fratricide of CD86 targeting CAR-T cells by defined logic-gate CAR strategy. |
|---|---|
| Authors: | Riet T; Department I of Internal Medicine, University Hospital Cologne and Faculty of Medicine, University of Cologne, 50937, Cologne, Germany.; Translational Research for Infectious Diseases and Oncology (TRIO), University Cologne, Robert Koch Str. 21, 50931, Cologne, Germany., Lennartz S; Department I of Internal Medicine, University Hospital Cologne and Faculty of Medicine, University of Cologne, 50937, Cologne, Germany.; Translational Research for Infectious Diseases and Oncology (TRIO), University Cologne, Robert Koch Str. 21, 50931, Cologne, Germany., Bösing N; Department I of Internal Medicine, University Hospital Cologne and Faculty of Medicine, University of Cologne, 50937, Cologne, Germany.; Translational Research for Infectious Diseases and Oncology (TRIO), University Cologne, Robert Koch Str. 21, 50931, Cologne, Germany., Prinz LF; Department I of Internal Medicine, University Hospital Cologne and Faculty of Medicine, University of Cologne, 50937, Cologne, Germany.; Translational Research for Infectious Diseases and Oncology (TRIO), University Cologne, Robert Koch Str. 21, 50931, Cologne, Germany., Dähn L; Department I of Internal Medicine, University Hospital Cologne and Faculty of Medicine, University of Cologne, 50937, Cologne, Germany.; Translational Research for Infectious Diseases and Oncology (TRIO), University Cologne, Robert Koch Str. 21, 50931, Cologne, Germany., Scheid C; Department I of Internal Medicine, University Hospital Cologne and Faculty of Medicine, University of Cologne, 50937, Cologne, Germany., Hallek M; Department I of Internal Medicine, University Hospital Cologne and Faculty of Medicine, University of Cologne, 50937, Cologne, Germany., Chmielewski MM; Department I of Internal Medicine, University Hospital Cologne and Faculty of Medicine, University of Cologne, 50937, Cologne, Germany. markus.chmielewski@uk-koeln.de.; Translational Research for Infectious Diseases and Oncology (TRIO), University Cologne, Robert Koch Str. 21, 50931, Cologne, Germany. markus.chmielewski@uk-koeln.de. |
| Source: | Experimental hematology & oncology [Exp Hematol Oncol] 2026 Jun 18; Vol. 15 (1). Date of Electronic Publication: 2026 Jun 18. |
| Publication Type: | Letter |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101590676 Publication Model: Electronic Cited Medium: Print ISSN: 2162-3619 (Print) Linking ISSN: 21623619 NLM ISO Abbreviation: Exp Hematol Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42316323 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Overcoming fratricide of CD86 targeting CAR-T cells by defined logic-gate CAR strategy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Riet+T%22">Riet T</searchLink>; Department I of Internal Medicine, University Hospital Cologne and Faculty of Medicine, University of Cologne, 50937, Cologne, Germany.; Translational Research for Infectious Diseases and Oncology (TRIO), University Cologne, Robert Koch Str. 21, 50931, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Lennartz+S%22">Lennartz S</searchLink>; Department I of Internal Medicine, University Hospital Cologne and Faculty of Medicine, University of Cologne, 50937, Cologne, Germany.; Translational Research for Infectious Diseases and Oncology (TRIO), University Cologne, Robert Koch Str. 21, 50931, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Bösing+N%22">Bösing N</searchLink>; Department I of Internal Medicine, University Hospital Cologne and Faculty of Medicine, University of Cologne, 50937, Cologne, Germany.; Translational Research for Infectious Diseases and Oncology (TRIO), University Cologne, Robert Koch Str. 21, 50931, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Prinz+LF%22">Prinz LF</searchLink>; Department I of Internal Medicine, University Hospital Cologne and Faculty of Medicine, University of Cologne, 50937, Cologne, Germany.; Translational Research for Infectious Diseases and Oncology (TRIO), University Cologne, Robert Koch Str. 21, 50931, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Dähn+L%22">Dähn L</searchLink>; Department I of Internal Medicine, University Hospital Cologne and Faculty of Medicine, University of Cologne, 50937, Cologne, Germany.; Translational Research for Infectious Diseases and Oncology (TRIO), University Cologne, Robert Koch Str. 21, 50931, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Scheid+C%22">Scheid C</searchLink>; Department I of Internal Medicine, University Hospital Cologne and Faculty of Medicine, University of Cologne, 50937, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Hallek+M%22">Hallek M</searchLink>; Department I of Internal Medicine, University Hospital Cologne and Faculty of Medicine, University of Cologne, 50937, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Chmielewski+MM%22">Chmielewski MM</searchLink>; Department I of Internal Medicine, University Hospital Cologne and Faculty of Medicine, University of Cologne, 50937, Cologne, Germany. markus.chmielewski@uk-koeln.de.; Translational Research for Infectious Diseases and Oncology (TRIO), University Cologne, Robert Koch Str. 21, 50931, Cologne, Germany. markus.chmielewski@uk-koeln.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101590676%22">Experimental hematology & oncology</searchLink> [Exp Hematol Oncol] 2026 Jun 18; Vol. 15 (1). <i>Date of Electronic Publication: </i>2026 Jun 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101590676 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2162-3619 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221623619%22">21623619 </searchLink><i>NLM ISO Abbreviation: </i>Exp Hematol Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42316323 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s40164-026-00791-3 Languages: – Code: eng Text: English Titles: – TitleFull: Overcoming fratricide of CD86 targeting CAR-T cells by defined logic-gate CAR strategy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Riet T – PersonEntity: Name: NameFull: Lennartz S – PersonEntity: Name: NameFull: Bösing N – PersonEntity: Name: NameFull: Prinz LF – PersonEntity: Name: NameFull: Dähn L – PersonEntity: Name: NameFull: Scheid C – PersonEntity: Name: NameFull: Hallek M – PersonEntity: Name: NameFull: Chmielewski MM IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 06 Text: 2026 Jun 18 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2162-3619 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Experimental hematology & oncology Type: main |
| ResultId | 1 |